Abstract
46,XX DSD comprises the most common group of genital variations, with congenital adrenal hyperplasia (CAH) being the most important, not only because of its frequency but also because of its life-threatening complications without treatment. The different conditions are described, showing the range of genetic and enzymatic anomalies that lead to excess androgen production, causing abnormal virilisation of a female foetus. The non-hormonal anatomical defects of genital development are also mentioned.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Achermann JC, Ito M, Hindmarsh PC, et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet. 1999;22(2):125–6.
Aittomaki K, Herva R, Stenman UH, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab. 1996;81(10):3722–6.
Aksglaede L, Jorgensen N, Skakkebaek NE, et al. Low semen volume in 47 adolescents and adults with 47,XXY Klinefelter or 46,XX male syndrome. Int J Androl. 2009;32(4):376–84.
al-Jurayyan NA. Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency in Saudi Arabia: clinical and biochemical characteristics. Acta Paediatr. 1995;84(6):651–4.
Arakane F, Kallen CB, Watari H, et al. Steroidogenic acute regulatory protein (StAR) acts on the outside of mitochondria to stimulate steroidogenesis. Endocr Res. 1998;24(3–4):463–8.
Baker BY, Lin L, Kim CJ, et al. Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J Clin Endocrinol Metab. 2006;91(12):4781–5.
Baumgartner-Parzer SM, Nowotny P, Heinze G, et al. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab. 2005;90(2):775–8.
Berenbaum SA. Cognitive function in congenital adrenal hyperplasia. Endocrinol Metab Clin N Am. 2001;30(1):173–92.
Berenbaum SA, Beltz AM, Bryk K, et al. Gendered peer involvement in girls with congenital adrenal hyperplasia: effects of prenatal androgens, gendered activities, and gender cognitions. Arch Sex Behav. 2018;47(4):915–29.
Biason-Lauber A, De Filippo G, Konrad D, et al. WNT4 deficiency–a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum Reprod. 2007;22(1):224–9.
Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet. 2000;67(6):15z.
Bongiovanni AM, Eberlein WR. Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. J Biol Chem. 1956;223(1):85–94.
Bose HS, Sugawara T, Strauss JF 3rd, et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International congenital lipoid adrenal hyperplasia consortium. N Engl J Med. 1996;335(25):1870–8.
Chung BC, Hu MC, Guzov VM, et al. Structure and expression of the CYP21 (P450c21, steroid 21-hydroxylase) gene with respect to its deficiency. Endocr Res. 1995;21(1–2):343–52.
Concolino P, Mello E, Zuppi C, et al. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations. Clin Chem Lab Med. 2010;48(8):1057–62.
Costa-Santos M, Kater CE, Auchus RJ. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab. 2004;89(1):49–60.
Croft B, Ohnesorg T, Hewitt J, et al. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9. Nat Commun. 2018;9(1):5319.
Darlington Statement. 2017. https://darlington.org.au.
Dessens AB, Slijper FME, Drop SLS. Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav. 2005;34(4):389–97.
Feder EK, Dreger A. Still ignoring human rights in intersex care. J Pediatr Urol. 2016;12(6):436–7.
Finkielstain GP, Chen W, Mehta SP, et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2010;96(1):E161–72.
Fluck CE, Pandey AV, Huang N, et al. P450 oxidoreductase deficiency–a new form of congenital adrenal hyperplasia. Endocr Dev. 2008;13:67–81.
Fujieda K, Tajima T. Molecular basis of adrenal insufficiency. Pediatr Res. 2005;57(5 Pt 2):62R–9R.
Fujieda K, Tajima T, Nakae J, et al. Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest. 1997;99(6):1265–71.
Hall CM, Jones JA, Meyer-Bahlburg HFL, et al. Behavioral and physical masculinization are related to genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2004;89(1):419–24.
Halper A, Hooke MC, Gonzalez-Bolanos MT, et al. Health-related quality of life in children with congenital adrenal hyperplasia. Health Qual Life Outcomes. 2017;15(1):194.
Hamed SA, Metwalley KA, Farghaly HS. Cognitive function in children with classic congenital adrenal hyperplasia. Eur J Pediatr. 2018;177(11):1633–40.
Higashi Y, Yoshioka H, Yamane M, et al. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci U S A. 1986;83(9):2841–5.
Hines M, Brook C, Conway GS. Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J Sex Res. 2004;41(1):75–81.
Hughes IA. Congenital adrenal hyperplasia. Trends Endocrinol Metab. 1990a;1(3):123–8.
Hughes IA. Monitoring treatment in congenital adrenal hyperplasia. Arch Dis Child. 1990b;65(3):333.
Imai T, Yanase T, Waterman MR, et al. Canadian mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency. Hum Genet. 1992;89(1):95–6.
Jaaskelainen J, Tiitinen A, Voutilainen R. Sexual function and fertility in adult females and males with congenital adrenal hyperplasia. Horm Res. 2001;56(3–4):73–80.
John M, Menon SK, Shah NS, et al. Congenital adrenal hyperplasia 11beta-hydroxylase deficiency: two cases managed with bilateral adrenalectomy. Singap Med J. 2009;50(2):e68–70.
Kacem M, Moussa A, Khochtali I, et al. Bilateral adrenalectomy for severe hypertension in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency: long term follow-up. Ann Endocrinol. 2009;70(2):113–8.
Kelso WM, Nicholls ME, Warne GL, et al. Cerebral lateralization and cognitive functioning in patients with congenital adrenal hyperplasia. Neuropsychology. 2000;14(3):370–8.
Khoury K, Barbar E, Ainmelk Y, et al. Gonadal function, first cases of pregnancy, and child delivery in a woman with lipoid congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2009;94(4):1333–7.
Kimberley N, Hutson JM, Southwell BR, et al. Vaginal agenesis, the hymen, and associated anomalies. J Pediatr Adolesc Gynecol. 2012;25(1):54–8.
Kolon TF, Ferrer FA, McKenna PH. Clinical and molecular analysis of XX sex reversed patients. J Urol. 1998;160(3 Pt 2):1169–72. discussion 1178.
Koppens PF, Hoogenboezem T, Degenhart HJ. Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes. Hum Genet. 2002;111(4–5):405–10.
Krob G, Braun A, Kuhnle U. True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology. Eur J Pediatr. 1994;153(1):2–10.
Levine LS, Dupont B, Lorenzen F, et al. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1981;53(6):1193–8.
Levine LS, Zachmann M, New MI, et al. Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group. N Engl J Med. 1978;299(17):911–5.
Lourenco D, Brauner R, Lin L, et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med. 2009;360(12):1200–10.
Lutfallah C, Wang W, Mason JI, et al. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 2002;87(6):2611–22.
MacKay D, Nordenstrom A, Falhammar H.Bilateral adrenalectomy in congenital adrenal hyperplasia: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2018. https://doi.org/10.1210/jc.2018-00217.
Meyer-Bahlburg HF. What causes low rates of child-bearing in congenital adrenal hyperplasia? J Clin Endocrinol Metab. 1999;84(6):1844–7.
Meyer-Bahlburg HF, Dolezal C, Baker SW, et al. Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav. 2008;37(1):85–99.
Meyer-Bahlburg HF, Gruen RS, New MI, et al. Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behav. 1996;30(4):319–32.
Miller WL. Steroid 17alpha-hydroxylase deficiency–not rare everywhere. J Clin Endocrinol Metab. 2004;89(1):40–2.
Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 1987;316(4):178–82.
Nordenstrom A, Forest MG, Wedell A. A case of 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis. Horm Res. 2007;68(4):204–8.
Parajes S, Loidi L, Reisch N, et al. Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency. J Clin Endocrinol Metab. 2010;95(2):779–88.
Razzaghy-Azar M, Karimi S, Shirazi E. Gender identity in patients with congenital adrenal hyperplasia. Int J Endocrinol Metab. 2017;15(3):e12537.
Robins T, Carlsson J, Sunnerhagen M, et al. Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia. Mol Endocrinol. 2006;20(11):2946–64.
Rosa S, Steigert M, Lang-Muritano M, et al. Clinical, genetic and functional characteristics of three novel CYP17A1 mutations causing combined 17alpha-hydroxylase/17,20-lyase deficiency. Horm Res Paediatr. 2010;73(3):198–204.
Rosler A, Leiberman E, Cohen T. High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet. 1992;42(6):827–34.
Rosler A, Levine LS, Schneider B, et al. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1977;45(3):500–12.
Rosler A, Weshler N, Leiberman E, et al. 11 Beta-hydroxylase deficiency congenital adrenal hyperplasia: update of prenatal diagnosis. J Clin Endocrinol Metab. 1988;66(4):830–8.
Simard J, Moisan AM, Morel Y. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency. Semin Reprod Med. 2002;20(3):255–76.
Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003;349(8):776–88.
Sutton E, Hughes J, White S, et al. Identification of SOX3 as an XX male sex reversal gene in mice and humans. J Clin Investig. 2011;121(1):328–41.
Tapanainen JS, Vaskivuo T, Aittomaki K, et al. Inactivating FSH receptor mutations and gonadal dysfunction. Mol Cell Endocrinol. 1998;145(1–2):129–35.
Tian Q, Yao F, Sha G, et al. Genotyping of a Chinese family with 46,XX and 46,XY 17-hydroxylase deficiency. Gynecol Endocrinol. 2009;25(8):485–90.
Tonkin-Hill G. Identifying the resource needs of adolescents with Differences of Sex Development. Faculty of Medicine, University of Melbourne, Melbourne; 2018.
Tucker EJ, Grover SR, Bachelot A, et al. Premature ovarian insufficiency: new perspectives on genetic cause and phenotypic spectrum. Endocr Rev. 2016;37(6):609–35.
Vallerie AM, Breech LL. Update in Müllerian anomalies: diagnosis, management, and outcomes. Curr Opin Obstet Gynecol. 2010;22(5):381–7.
Van Wyk JJ, Gunther DF, Ritzen EM, et al. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1996;81(9):3180–90.
Van Wyk JJ, Ritzen EM. The role of bilateral adrenalectomy in the treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2003;88(7):2993–8.
Vorona E, Zitzmann M, Gromoll J, et al. Clinical, endocrinological, and epigenetic features of the 46,XX male syndrome, compared with 47,XXY Klinefelter patients. J Clin Endocrinol Metab. 2007;92(9):3458–65.
White PC, Medscape. Neonatal screening for congenital adrenal hyperplasia. Nat Rev Endocrinol. 2009;5(9):490–8.
Wisniewski AB, Migeon CJ, Meyer-Bahlburg HF, et al. Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J Clin Endocrinol Metab. 2000;85(8):2664–9.
Wudy SA, Hartmann M, Homoki J. Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using benchtop gas chromatography-mass spectrometry. J Endocrinol. 2000;165(3):679–83.
Zainuddin AA, Grover SR, Soon CH, et al. A Multi-center cross-sectional study of Malaysian females with congenital adrenal hyperplasia: Their body image and their persepctives on feminizing surgery. J Pediatr Adolesc Gynecol. 2020 (epub ahead of print 3 May 2020).
Acknowledgements
With acknowledgements and thanks to the original writers of this chapter: Professor Garry L. Warne, Dr. Jacqueline Hewitt.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
O’Connell, M.A., Grover, S.R., Bouty, A. (2020). 46,XX DSD. In: Hutson, J., Grover, S., O'Connell, M., Bouty, A., Hanna, C. (eds) Disorders|Differences of Sex Development. Springer, Singapore. https://doi.org/10.1007/978-981-13-7864-5_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-7864-5_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7863-8
Online ISBN: 978-981-13-7864-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)